HypertensionGoFreshRxNCT05393232
Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension
A study testing Dietitian-Assisted DASH groceries and Self-directed shopping in people with Hypertension, run by Beth Israel Deaconess Medical Center at 1 site in United States.
Trial summary
GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food deserts. Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Hypertension
- What is being tested?
- Dietitian-Assisted DASH groceries and Self-directed shopping
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 176 participants
- Where
- 1 siteUnited States
- Study dates
- 13 Oct 2022to 25 May 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Self-reported/self-identified as Black or African American
- Resting systolic blood pressure of 120 to <150 mm Hg and diastolic blood pressure <100 mm Hg
- Active treatment with medications intended for hypertension treatment within the last 6 months at stable doses
- Residence in communities identified as Boston area food deserts: Brighton, Chelsea, Dorchester, East Boston, Everett, Hyde Park, Jamaica Plain, Malden, Mattapan, Revere, Roslindale, Roxbury, or Winthrop
- Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 12-week period
- Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
- Have access to mobile device or computer to be able to conduct grocery orders via video conference or by phone
- Willing and able to complete required measurement procedures
Who cannot join
- Laboratory Exclusions:
- Serum potassium ≥5.0 mmol/L or <3.5 mmol/L
- Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
- Hemoglobin A1c ≥6.5%
- Medication Exclusions:
- Unstable doses of medications that lower blood pressure or medications intended for hypertension treatment (including antihypertensives taken for non-hypertension purposes) within the last 6 months
Show all 42Show fewer
- Unstable doses (i.e. a change in the 2 months prior to screening or randomization) of the following:
- Sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Stimulants
- Inhaled or oral medications for asthma or chronic obstructive pulmonary disease (COPD)
- Hormone replacement therapy or thyroid hormone
- Weight-increasing psychotropic agents, including antipsychotic agents, lithium, and mirtazapine
- Use of any of the following medications:
- Potassium supplement, except if part of a multivitamin
- Warfarin (Coumadin)
- Chronic oral corticosteroid (intermittent use is okay)
- Weight loss medications (including GLP-1 receptor agonists)
- Unwillingness to keep same dose of vitamin, mineral, and botanical supplements
- Any medication not compatible with participation as determined by the investigators
- Physical Exclusions:
- Systolic blood pressure ≥150 mm Hg or diastolic blood pressure ≥100 mm Hg
- Body weight >420 pounds
- Arm circumference >50cm
- Weight loss or gain of >5.0% of body weight during prior 2 months
- Medical History Exclusions:
- Type 1 or Type 2 Diabetes defined as a hemoglobin A1c ≥6.5% or diabetes treatment
- Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
- Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
- Active inflammatory bowel disease, bowel resection, malabsorptive syndrome, pancreatitis (episode within past year), or history of bariatric surgery
- Pregnancy or lactation or planned pregnancy
- Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
- Any other serious illness or condition not compatible with participation as determined by the investigators
- Lifestyle and Other Exclusions:
- Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
- Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
- Active substance use disorder that would interfere with participation
- Extreme food insecurity
- Participation in or planning to start weight loss program
- Current participation in another clinical trial that could interfere with the study protocol
- Anticipated change in residence prior to the end of the study
- Families with more than 6 adults at dinner time (children are considered to be half an adult)
- Investigator discretion
Trial locations and contacts
1 site in 1 country.
United States1 site
Beth Israel Deaconess Medical Center - Clinical Research Center
Boston, Massachusetts, 02215
About this study
Official title: Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts With Treated Hypertension
GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food deserts.
Read the detailed description
Hypertension affects over half of Black adults in the United States - more than any other group - and diet is a principal determinant of disparities in hypertension among Black adults. While the DASH diet is a proven strategy for lowering blood pressure in Black adults, diet disparities are increasing in urban food deserts due to poor access and the high costs of healthy foods. Our proposed clinical trial will randomize 150 Black adults, who are actively treated for hypertension and reside in Boston area urban food deserts to either:
- 12 weeks of dietitian-assisted, DASH grocery delivery via an online, virtual grocery store at an amount sufficient to replace all Calorie needs of each participant, allowing for some sharing with family members or
- Self-directed shopping with a monthly stipend over a 3-month period
After the 12-week intervention phase, participants will undergo a 9-month observation phase. At 3-months after the intervention is complete the investigators will repeat in-person study assessments and perform qualitative interviews in a subset of the population to determine barriers and facilitators to intermediate-term maintenance of the intervention. At 9-months after the intervention, participants will participate in a phone visit designed to assess longer-term maintenance of the intervention.
- Conditions
- Hypertension
- Being tested
- Dietitian-Assisted DASH groceries, Self-directed shopping
- Keywords
- hypertension, blood pressure, nutrition, diet, DASH, sodium, trial, dietitian, cholesterol
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dietitian-Assisted DASH groceriesBehavioural
The DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages.
Intervention Phase:
This intervention is a weekly, 12-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size.
Observation Phase:
For months 4-12 of the study, participants will be asked to continue following a DASH grocery shopping pattern without the provision of weekly groceries.
Self-directed shoppingBehavioural
Intervention Phase:
Participants will receive some basic information on healthy eating and a monthly stipend at 4, 8, and 12-weeks of the intervention.
Observation Phase:
For months 4-12 of the study, participants will be asked to follow their typical shopping pattern without the provision of a monthly stipend.
| Study group | Role | What they receive |
|---|---|---|
| Dietitian-Assisted DASH groceries | Experimental | Participants will order groceries sufficient to meet their caloric needs each week for 12 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions. During the remainder of the study (months 4-12), participants will be asked to apply what they learned without the provision of groceries. Receives: Behavioral: Dietitian-Assisted DASH groceries |
| Self-directed shopping (referent assignment) | Active comparator | Participants will receive a monthly stipend over a 3 month period and some basic information about healthy eating. The stipend is not restricted to foods. During the remainder of the study (months 4-12), participants will be asked to continue their typical shopping without the provision of the monthly stipend. Receives: Behavioral: Self-directed shopping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Seated, office-based, systolic blood pressure (intervention phase)
In-person, measured with an automated oscillometric device that will perform 3 measurements.
Measured: Measured 3 months after randomization
Secondary outcomes (12)
Seated, office-based, systolic blood pressure (observation phase)
In-person, measured with an automated oscillometric device that will perform 3 measurements.
Measured: Measured 6 months after randomization
Seated, office-based, diastolic blood pressure (intervention & observation phases)
In-person, measured with an automated oscillometric device that will perform 3 measurements.
Measured: Measured 3 and 6 months after randomization
Ambulatory blood pressure monitoring: wake-time systolic and diastolic blood pressure (intervention & observation phases)
Ambulatory blood pressure monitoring with a mobile blood pressure device that will measure blood pressure over a 24-hour period.
Measured: Measured 3 and 6 months after randomization
Body Mass Index (BMI) (intervention & observation phases)
In-person, measurement based on height and weight. Height is measured via a stadiometer and weight is measured via calibrated scale.
Measured: Measured 3 and 6 months after randomization
24-hour urine potassium (intervention & observation phases)
Collected at home after a clinic void over a 24-hour period
Measured: Measured 3 and 6 months after randomization
24-hour urine sodium (intervention & observation phases)
Collected at home after a clinic void over a 24-hour period
Measured: Measured 3 and 6 months after randomization
Hemoglobin A1c (intervention & observation phases)
In-person blood collection; measure of glycemia over the preceding 3 months
Measured: Measured 3 and 6 months after randomization
Lipids (intervention & observation phases)
Measured in fasted serum specimens collected during phlebotomy. Includes total cholesterol, high density lipoprotein cholesterol, derived low density lipoprotein cholesterol, and triglycerides
Measured: Measured 3 and 6 months after randomization
Serum potassium (intervention & observation phases)
Measured in blood as part of a basic metabolic panel
Measured: Measured 3 and 6 months after randomization
Serum creatinine (intervention & observation phases)
Measured in blood as part of a basic metabolic panel
Measured: Measured 3 and 6 months after randomization
Daily intake of fat, fruits, and vegetables (intervention & observation phases)
Assessed via questionnaire in-person and via phone call; assessed via a validated food screener (Block et al; PMID: 10788730).
Measured: Measured 3, 6, and 12 months after randomization
24-hour dietary recall (intervention & observation phases)
Assessed via questionnaire in-person using the Automated Self-Administered 24-Hour Dietary Recall (ASA24)
Measured: Measured 3 and 6 months after randomization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2022
- Study start13 Oct 2022
- Primary completion11 Aug 2025
- Study completion25 May 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for HypertensionStudies of the same condition, open and under way.
- More trials run by Beth Israel Deaconess Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Individual level, parallel, randomized trial
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 176 participants (actual)
Sponsor and investigators
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Principal investigator, Stephen Juraschek, Beth Israel Deaconess Medical Center
- Investigators
- Stephen P Juraschek, MD, PhD, Principal investigator, Beth Israel Deaconess Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05393232
- Sponsor's protocol ID
- 2022P000221
- Other IDs
- R01MD016068
- Acronym
- GoFreshRx
- Status last verified
- Jan 2026
- First submitted
- 23 May 2022
- Last updated
- 8 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: This project is complementary to the GoFresh Study (funded by the American Heart Association) with the purpose of creating a pooled resource of the two trials for secondary data analysis. Participants will be informed of sharing planning during the informed consent process.
Publications
Cao J, Cha J, Harry T, Plante TB, Col H, Patil D, Turkson-Ocran RN, Feng Y, Hermosilla M, Zhang M, Juraschek SP. Motivational themes in digital advertisements enhance recruitment efficiency in cardiovascular trials. Contemp Clin Trials. 2026 Jul 24;169:108413. doi: 10.1016/j.cct.2026.108413. Online ahead of print.
PubMed 42498080Juraschek SP, Col H, Ferro K, Turkson-Ocran RN, Cluett JL, Davis RB, Kraemer KM, McManus K, Mukamal KJ, Aidoo EL, Larbi Kwapong F, Budu M, Patil D, Nartey S, Michetti J, Allison S, Mate-Kole M, Cao J, Grobman B, Seager R, Hines AL, Miller ER 3rd, Crews DC, Papajorgji-Taylor D, Fitzpatrick SL. DASH-patterned groceries and effects on blood pressure in adults treated for hypertension: the GoFreshRx randomized trial. Nat Med. 2026 Jun;32(6):2128-2136. doi: 10.1038/s41591-026-04319-4. Epub 2026 Mar 28.
PubMed 41904226Harry T, Hussain Z, Cao J, Turkson-Ocran RN, Juraschek SP, Michos ED, Miller HN, Lahey TP, Plante TB, Feng Y. Randomized Comparison of Online Motivational Themes in Clinical Trial Recruitment. Circ Cardiovasc Qual Outcomes. 2025 Dec;18(12):e012945. doi: 10.1161/CIRCOUTCOMES.125.012945. Epub 2025 Nov 7.
PubMed 41201904
Study at a glance
From the registry record, last updated by the sponsor on 8 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts With Treated Hypertension
- ClinicalTrials.gov ID
- NCT05393232
- Acronym / sponsor ID
- GoFreshRx / 2022P000221
- Conditions
- Hypertension
- Keywords
- hypertension, blood pressure, nutrition, diet, DASH, sodium, trial, dietitian
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 176 participants (actual)
- Lead sponsor
- Beth Israel Deaconess Medical CenterUniversity, hospital or other
- Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
- Study start
- 13 Oct 2022 (actual)
- Primary completion
- 11 Aug 2025 (actual)
- Study completion
- 25 May 2026 (actual)
- First posted
- 26 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food deserts.
Detailed description
Hypertension affects over half of Black adults in the United States - more than any other group - and diet is a principal determinant of disparities in hypertension among Black adults. While the DASH diet is a proven strategy for lowering blood pressure in Black adults, diet disparities are increasing in urban food deserts due to poor access and the high costs of healthy foods. Our proposed clinical trial will randomize 150 Black adults, who are actively treated for hypertension and reside in Boston area urban food deserts to either:
- 12 weeks of dietitian-assisted, DASH grocery delivery via an online, virtual grocery store at an amount sufficient to replace all Calorie needs of each participant, allowing for some sharing with family members or
- Self-directed shopping with a monthly stipend over a 3-month period
After the 12-week intervention phase, participants will undergo a 9-month observation phase. At 3-months after the intervention is complete the investigators will repeat in-person study assessments and perform qualitative interviews in a subset of the population to determine barriers and facilitators to intermediate-term maintenance of the intervention. At 9-months after the intervention, participants will participate in a phone visit designed to assess longer-term maintenance of the intervention.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Individual level, parallel, randomized trial
| Arm | Type | Receives |
|---|---|---|
| Dietitian-Assisted DASH groceries | Experimental | Behavioral: Dietitian-Assisted DASH groceriesParticipants will order groceries sufficient to meet their caloric needs each week for 12 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions. During the remainder of the study (months 4-12), participants will be asked to apply what they learned without the provision of groceries. |
| Self-directed shopping (referent assignment) | Active comparator | Behavioral: Self-directed shoppingParticipants will receive a monthly stipend over a 3 month period and some basic information about healthy eating. The stipend is not restricted to foods. During the remainder of the study (months 4-12), participants will be asked to continue their typical shopping without the provision of the monthly stipend. |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Self-reported/self-identified as Black or African American
- Resting systolic blood pressure of 120 to <150 mm Hg and diastolic blood pressure <100 mm Hg
- Active treatment with medications intended for hypertension treatment within the last 6 months at stable doses
- Residence in communities identified as Boston area food deserts: Brighton, Chelsea, Dorchester, East Boston, Everett, Hyde Park, Jamaica Plain, Malden, Mattapan, Revere, Roslindale, Roxbury, or Winthrop
- Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 12-week period
Key exclusion criteria (42 listed)
- Serum potassium ≥5.0 mmol/L or <3.5 mmol/L
- Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
- Hemoglobin A1c ≥6.5%
- Unstable doses of medications that lower blood pressure or medications intended for hypertension treatment (including antihypertensives taken for non-hypertension purposes) within the last 6 months
- Unstable doses (i.e. a change in the 2 months prior to screening or randomization) of the following:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dietitian-Assisted DASH groceriesThe DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages. Intervention Phase: This intervention is a weekly, 12-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size. Observation Phase: For months 4-12 of the study, participants will be asked to continue following a DASH grocery shopping pattern without the provision of weekly groceries. | Behavioural | Dietitian-Assisted DASH groceries |
| Self-directed shoppingIntervention Phase: Participants will receive some basic information on healthy eating and a monthly stipend at 4, 8, and 12-weeks of the intervention. Observation Phase: For months 4-12 of the study, participants will be asked to follow their typical shopping pattern without the provision of a monthly stipend. | Behavioural | Self-directed shopping (referent assignment) |
Primary outcome
Seated, office-based, systolic blood pressure (intervention phase)
Time frame: Measured 3 months after randomization
In-person, measured with an automated oscillometric device that will perform 3 measurements.
12 secondary outcomes
Seated, office-based, systolic blood pressure (observation phase)
Time frame: Measured 6 months after randomization
Seated, office-based, diastolic blood pressure (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Ambulatory blood pressure monitoring: wake-time systolic and diastolic blood pressure (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Body Mass Index (BMI) (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
24-hour urine potassium (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
24-hour urine sodium (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Hemoglobin A1c (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Lipids (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Serum potassium (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Serum creatinine (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Daily intake of fat, fruits, and vegetables (intervention & observation phases)
Time frame: Measured 3, 6, and 12 months after randomization
24-hour dietary recall (intervention & observation phases)
Time frame: Measured 3 and 6 months after randomization
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jul 2026.
- Derived from this study: PubMed 42498080Cao J, Cha J, Harry T, Plante TB, Col H, Patil D, Turkson-Ocran RN, Feng Y, Hermosilla M, Zhang M, Juraschek SP. Motivational themes in digital advertisements enhance recruitment efficiency in cardiovascular trials. Contemp Clin Trials. 2026 Jul 24;169:108413. doi: 10.1016/j.cct.2026.108413. Online ahead of print.
- Derived from this study: PubMed 41904226Juraschek SP, Col H, Ferro K, Turkson-Ocran RN, Cluett JL, Davis RB, Kraemer KM, McManus K, Mukamal KJ, Aidoo EL, Larbi Kwapong F, Budu M, Patil D, Nartey S, Michetti J, Allison S, Mate-Kole M, Cao J, Grobman B, Seager R, Hines AL, Miller ER 3rd, Crews DC, Papajorgji-Taylor D, Fitzpatrick SL. DASH-patterned groceries and effects on blood pressure in adults treated for hypertension: the GoFreshRx randomized trial. Nat Med. 2026 Jun;32(6):2128-2136. doi: 10.1038/s41591-026-04319-4. Epub 2026 Mar 28.
- Derived from this study: PubMed 41201904Harry T, Hussain Z, Cao J, Turkson-Ocran RN, Juraschek SP, Michos ED, Miller HN, Lahey TP, Plante TB, Feng Y. Randomized Comparison of Online Motivational Themes in Clinical Trial Recruitment. Circ Cardiovasc Qual Outcomes. 2025 Dec;18(12):e012945. doi: 10.1161/CIRCOUTCOMES.125.012945. Epub 2025 Nov 7.
- Main trial website (shared with the GoFresh Trial)Link provided by the sponsor.
- Individual participant dataSharing planned: Yes. This project is complementary to the GoFresh Study (funded by the American Heart Association) with the purpose of creating a pooled resource of the two trials for secondary data analysis. Participants will be informed of sharing planning during the informed consent process.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stephen P Juraschek, MD, PhD principal investigator
Beth Israel Deaconess Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dietitian-Assisted DASH groceries and Self-directed shopping in people with Hypertension, run by Beth Israel Deaconess Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 42 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Seated, office-based, systolic blood pressure (intervention phase) (time frame: Measured 3 months after randomization). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05393232, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.